Study period | Screening | Baseline | Intervention | Follow-up | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Time | 14–1 days prior to baseline | 0 (14–0 days prior to first training session) | Week 1 | Week 2 | Week 3 | Week 4 | Week 5 | Week 6 | Week 8 | Week 10 | Week 12 | Week 14 | Week 16 | Week 18 | Week 20 | + 6 months after week 20 | + 12 months after week 20 |
Enrolment | |||||||||||||||||
 Preliminary informed consent for FACIT-F administration | X |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
 Eligibility screen | X |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
 Informed consent | X |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
 Randomization |  | X |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Intervention | |||||||||||||||||
 ERYT/CoordiFit sessions |  |  | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 |  |  |
Assessments | |||||||||||||||||
 Medical history and treatments |  | X |  |  |  |  |  |  |  |  |  |  |  |  | X |  |  |
 Patient’s Baseline questionnaire |  | X |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
 FACIT-F | X1 |  |  |  |  |  |  |  | X |  |  | X |  |  | X | X | X |
 PSQI |  | X |  |  |  |  |  |  | X |  |  | X |  |  | X | X | X |
 PHQ-9 and GAD-7 |  | X |  |  |  |  |  |  |  |  |  |  |  |  | X | X | X |
 BPI |  | X |  |  |  |  |  |  | X |  |  | X |  |  | X | X | X |
 PRFS |  | X |  |  |  |  |  |  |  |  |  |  |  |  | X | X | X |
 NCCN Distress Thermometer |  | X |  |  |  |  |  |  | X |  |  | X |  |  | X | X | X |
 Mobility of the arm |  | X |  |  |  |  |  |  | X |  |  | X |  |  | X | X | X |
 Therapist’s Questionnaire |  |  | X | X | X | X | X | X | X | X | X | X | X | X | X |  |  |
 Patient diary |  |  | Every day |  |  | ||||||||||||
 Patient’s Last Session questionnaire |  |  |  |  |  |  |  |  |  |  |  |  |  |  | X |  |  |
 Patient’s Follow-up questionnaire |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | X | X |
 End of Study questionnaire |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | X |